Suzanne Mary Michalek

Title: Suzanne Mary Michalek: Innovator in Mucosal Immunogens for Novel Vaccines

Introduction

Suzanne Mary Michalek is a prominent inventor based in Birmingham, AL (US). She has made significant contributions to the field of immunology, particularly in the development of novel vaccines. Her innovative work focuses on mucosal immunogens, which play a crucial role in enhancing immune responses.

Latest Patents

Suzanne holds a patent for "Mucosal immunogens for novel vaccines." This invention provides chimeric proteins, such as Salivary Binding Protein (SBR) coupled to the B subunit of cholera toxin. The chimeric protein, when expressed in attenuated Salmonella typhimurium, produces significant increases in serum IgG and salivary IgA antibody levels after oral immunization. Additionally, the recombinant plasmid contains a salivary binding protein-cholera toxin A2/B chimeric protein expressed in E. coli. Intragastric immunization of SBR coupled to CTB in this chimeric protein form leads to increased antigen-responsive T cells. Furthermore, oral immunization using this recombinant plasmid results in increased serum IgG responses to antigen and increased salivary IgA antibody responses.

Career Highlights

Suzanne is affiliated with the UAB Research Foundation, where she continues her research and development in immunology. Her work has garnered attention for its potential applications in vaccine development and public health.

Collaborations

Some of her notable coworkers include Michael W. Russell and Georgios Hajishengallis. Their collaborative efforts contribute to advancing research in the field of immunology.

Conclusion

Suzanne Mary Michalek is a trailblazer in the development of mucosal immunogens for vaccines, with her innovative patent showcasing her expertise and dedication to enhancing immune responses. Her contributions are vital to the ongoing advancements in vaccine technology.